Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Big news for TILT will be when shipping restrictions are lifted.
The problem I have with tILT is the stock price does not reflect the company's successes. 330,000,000 s/o ... not bad. I was buying hand over fist earlier in the teens.
TLLTF
Tilt Holdings Inc.
Ordinary Shares
0.3004
-0.011
-3.53%
0.2975 / 0.3033 (44000 x 2500)
OTC DISCLOSURE & NEWS SERVICE
TILT Holdings Reports Third Quarter 2021 Financial Results; Record Quarterly Revenue of $53.4 Million, Up 37% YoY and 10% QoQ
PHOENIX, Nov. 15, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (NEO:TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three-months and nine-months ended September 30, 2021. All financial information is provided in U.S. dollars unless otherwise indicated.
“TILT’s B2B strategy originated from our belief that the rising supply of wholesale cannabis in multiple markets across the U.S. would require a differentiated approach, shifting away from bulk flower sales towards branded packaged goods,” said Gary Santo, CEO of TILT. “When we launched our strategy at the start of the year, we envisioned that marketplace transition would take 12 to 18 months as new cultivation came online. In the third quarter, we saw that timeline accelerate along with macro-economic pressure impacting consumers.”
“Competition for shelf space is accelerating. Compressing margins are forcing MSOs and SSOs to focus on their own branded products while still maintaining a portion of that shelf space for a curated portfolio of high demand third-party products. This is the space where TILT plays, and although we are still early in scaling our operations to meet brand partner demand, our top-line performance during the quarter demonstrates that by establishing partnerships with the right brands at the right price points, TILT can support retailers while expanding the reach of independent brands.”
“While we expect ongoing improvements in our efficiency and margin profile in our cannabis business as we ramp cultivation, Jupiter continues to lead the way in cannabis inhalation devices with record revenue during the quarter. Our supply chain management expertise has been on full display throughout the year, and while there has been a near-term impact to our margins due to higher freight costs, our ability to strategically deploy working capital to ensure availability of product has benefitted our customers while attracting the business of our competitors’ customers.”
The Company reiterates its 2021 revenue guidance of $205-$210 million, expecting to come in at the lower end of the range primarily as a result of unexpected delays in obtaining new product approvals in Pennsylvania. This, coupled with higher freight costs associated with the Company’s inhalation and accessories business and expanding cultivation in Massachusetts, has resulted in the Company revising its 2021 adjusted EBITDA outlook to range between $24-$26 million, representing a 42%-54% increase compared to 2020.
Q3 2021 Financial Summary (vs. Q3 2020, where applicable)
Revenue increased 37% to $53.4 million driven by growth in both cannabis and inhalation and accessory revenue. Cannabis revenue increased 19% to $11.2 million and inhalation and accessory revenue increased 42% to $42.1 million.
Gross profit before fair value adjustments increased to $12.7 million or 23.7% of revenue, compared to $12.2 million or 31.3% of revenue.
Gross margins were impacted by higher freight costs for the Company’s inhalation and accessory business, as well as ramping cultivation in the Company’s cannabis business.
Total operating expense was $16.3 million compared to $14.5 million. As a percentage of revenue, opex improved to 30.5% compared to 37% in the year ago quarter as a result of better operating efficiencies.
Adjusted EBITDA was $5.0 million compared to $5.1 million.
As a percentage of revenue, adjusted EBITDA was 9.3% compared to 13.1%.
At September 30, 2021, cash and cash equivalents was $6.7 million compared to $7.4 million at December 31, 2020.
Working capital increased to $64.9 million compared to $57.4 million at December 31, 2020.
Q3 2021 Operational Highlights
Received approval to commence medical retail sales at the Company’s Brockton, Massachusetts dispensary; grand opening took place in October.
Announced partnership with the Shinnecock Indian Nation to enter New York’s cannabis market.
Expanded partnership with Old Pal to bring select products to market in Pennsylvania.
The problem I've had all along with TILT is that they can't make an money, no matter how much they sell. For the past 5 quarters cost of goods sold ALWAYS comes in way higher than revenues.
You can blow the revenue numbers out of the water, but if you can't make any money doing it, what's the point?
What is their path to profitability? Just acquiring more brands for the sake of growth isn't a good business plan.
TOAST!!
Tilt To Sell Toast In Several States
The Daily Hit: February 17, 2022
TILT Holdings Inc. (OTCQX: TLLTF) has made a deal to manufacture and distribute the Colorado-based cannabis brand Toast. Toast is known for its USDA organic certified tinctures and its vegan, raw chocolate. The company has also made a name for its signature Slice pre-rolls.
“Toast is well-known for its impressive craftsmanship and will be a welcome addition in our markets,” said Gary Santo, CEO of TILT Holdings. “Toast is an innovative, high-touch brand, making it a natural fit for TILT’s brand growth strategy as we strive to provide medical patients and adult-use consumers with a wider range of quality options.”
Tilt said the initial product rollout would begin in Massachusetts through its subsidiary Commonwealth Alternative Care, Inc. If the company gets approval, Tilt said it will launch Toast in Pennsylvania and Ohio through its Standard Farms subsidiaries with new SKUs created for each market. Tilt also said it will provide full-service wholesale manufacturing, packaging and distribution for several existing Toast SKUs, as well as collaborative R&D services to create new products and increase the accessibility of high-end cannabis to medical patients and adult-use consumers.
“We are committed to expanding access to our quality, life-enhancing products to medical patients and creating celebratory moments for adult-use consumers around the country,” said Punit Seth, CEO and Co-Founder of Toast. “From the beginning, TILT and Toast have had a shared vision about the best model to scale brands in multiple states while staying true to our values and commitment to building a more equitable industry overall. TILT will be crucial in bringing Toast products to scale in these three growing markets, and we are excited to collaborate with their team as they explore additional markets such as New York through their ground-breaking partnership with the Shinnecock Indian Nation.”
Toast™ products offer patients and consumers quality experiences that span the full spectrum of the plant. In the coming months, Toast™ will debut a new set of SKUs with TILT that are currently under development specially curated for each market.
Here's the pump...
https://www.marijuanamoment.net/schumer-gives-update-on-federal-marijuana-legalization-and-banking-in-meeting-with-equity-advocates/
And here's the dump...
https://www.marijuanamoment.net/mcconnell-blasts-marijuana-banking-in-house-passed-china-bill-calling-it-a-poison-pill/
And fortunately, TILT got out AHEAD of this potential PR disaster, and turned it into a PR WIN!...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167798893
Not a P&D.
$0.299 holding up nicely.
Dumpathon!!
I picked up about 1,500 shares at $0.305 this morning.
Now 0.3255
Still 0.3069
Target $0.50
150%
Good to see it bounce. We were getting close to March 2020 lows :)
Geez, John, sounds like you might be a little excited about the base ramp jump. Hope it continues!
A sight to behold! Let's see if it LASTS.
PRICE ALERT
Price Currency Change Tick Pct. Change Bid Ask Prev. Close Vol
0.2605 USD 0.0264 U 11.277232 0.254 0.2604 0.2341 595,124
Another add right here.
New price alert at $0.24
Next alert is at $0.22
$0.17 to $0.20
BOTTOM
I agree. I will do my best to add as many shares as I can sub $0.20
Outstanding Shares
330,346,380
01/24/2022
Insanely cheap, but here we are!
Flirting w/ March 2020 lows
All my stink bids filled & added a couple more for good measure:)
Source: Marijuana Moment
As cannabis becomes more mainstream, companies in the pharmaceutical, consumer packaged-goods, alcohol, and tobacco spaces are going to want in, according to venture capitalists focused on the cannabis industry.
That could mean more capital for the cannabis industry, which is still being funded in large part by family offices and cannabis-focused venture-capitalist firms, because mainstream investors are reluctant to touch an industry selling a product that is still federally illegal.
Those investments might also lead to further normalization of the industry, which, in turn, could potentially create a push for more regulatory reform.
Insider talked to 14 top cannabis VCs who collectively invested $925.8 million into the industry in 2021 to ask them about what we should expect over the next year. Two of them told us that they predict a rise in mainstream companies making deals with cannabis businesses.
“We expect to see several high-profile strategic transactions from non-cannabis companies looking to enter the space,” Jason Wild, the president and chief investment officer of JW Asset Management, told Insider. The firm invested $22.5 million into private cannabis companies in 2021, across 11 deals.
Several others said they expected more institutional capital to turn to the cannabis industry as it becomes more mainstream.
Big tobacco and alcohol firms like Altria and Constellation Brands have already made large investments into cannabis, but so far their efforts have focused on companies that operate in Canada, where marijuana is legal under federal law.
Large consumer packaged-goods companies also invested in cannabis businesses as the industry was getting off the ground in Canada, but the adult-use market there failed to meet lofty expectations.
Cannabis investments were heavily focused on the US in 2021
In recent years, much of the funding in the space has turned to the US, where cannabis companies operate under a state-by-state framework — meaning that even if they are growing and selling marijuana in accordance with state regulations, they’re still operating illegally under federal law.
In 2021, US investments made up over 85% of the total $2.7 billion invested in cannabis start-ups globally. Legalization efforts have also ramped up, as voters in states like New Jersey, New York, and Arizona have supported legislation to legalize cannabis. Big brands like Amazon have also signaled support for federal cannabis legalization.
Gregory Heyman, a managing partner at Beehouse, told Insider that in 2022 he expects big companies from the pharmaceutical, consumer packaged-goods, alcohol, and tobacco industries to make strategic investments into “plant-touching” cannabis businesses, or companies that grow and sell cannabis directly.
Beehouse invested $30 million across five private cannabis businesses in 2021 and has over $300 million in assets under management.
Companies in these other industries “are losing market share to cannabis products that offer cheaper, better, safer, more specific, and healthier alternatives favored by first-time and longtime cannabis users across every demographic,” Heyman said.
He added that investments from mature industries would futher propel normalization and legalization and encourage other institutions and individuals to invest in the space.
https://seekingalpha.com/article/4476045-10-predictions-for-us-cannabis-in-2022
Tilt is mentioned numerous times , with huge upside potential
Oh wow. I forgot I owned this stock.
Some good nuggets on this interview
Interested if we test 52 week lows?...21-ish.
Weird stuff happens late late December.
Between tax loss season and low liquidity, never know.
Have a couple stink bids in.
Ready and waiting.
Thanks, hopefully!
I feel comfortable peppering in some adds down here.
No problem adding under $100M market cap.
GL
A very wise decision on your part my fine feathered. Very wise indeed.
TILT to Participate in Upcoming Investor Conferences
11/23/21 1:55 PM ET (GlobeNewswire)Print
TILT Holdings Inc. ("TILT" or the "Company") (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced that its executive team will participate at two upcoming investor conferences in December 2021:
For more information about the conferences or to schedule a one-on-one meeting with TILT management, please contact the Company's investor relations team at investors@tiltholdings.com.
About TILT
TILT helps cannabis businesses build brands. Through a portfolio of companies providing technology, hardware, cultivation and production, TILT services brands and cannabis retailers across 36 states in the U.S., as well as Canada, Israel, Mexico, South America and the European Union. TILT's core businesses include Jupiter Research LLC, a wholly-owned subsidiary and leader in the vaporization segment focused on hardware design, research, development and manufacturing; and cannabis operations, Commonwealth Alternative Care, Inc. in Massachusetts, Standard Farms LLC in Pennsylvania, Standard Farms Ohio, LLC in Ohio, and its partnership with the Shinnecock Indian Nation in New York. TILT is headquartered in Phoenix, Arizona. For more information, visit www.tiltholdings.com.
Adult-Use-Retail-Establishment-License./TILT-Holdings-Celebrates-Brockton-Medical-Dispensary-Grand-Opening-Receives-Final-Adult-Use-Retail-Establishment-License